Study Evaluating The Potential Effect Of Rifampin On The Pharmacokinetics Of Neratinib

• Status: Completed
• Trial end date: 2009-05-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to examine whether co-administration of rifampin with neratinib has an effect on the pharmacokinetics (how the body absorbs, distributes, metabolizes and/or excretes) of neratinib.

• Phase: Phase 1
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Puma Biotechnology, Inc.
• Treatments: Rifampin

Criteria

Inclusion criteria:

• Healthy men or women (of non childbearing potential)

• Ages 18 to 50 years old.